Jonathan Trent
Tracked across 1 events · 7 articles · First seen Apr 16, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jonathan Trent, MD of the University of Miami, Sylvester Comprehensive Cancer Center, commented on the significant advancement the Phase 2 trial for STC-15 represents in sarcoma treatment.
Apr 16, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Jonathan Trent live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard